相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model
Asahi Ito et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting
Kunihiro Tsukasaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Augmentation of antitumour activity of defucosylated chimeric anti-CCR4 monoclonal antibody in SCID mouse model of adult T-cell leukaemia/lymphoma using G-CSF
Hiroki Yano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Molecular origins of cancer - Cancer immunology
Olivera J. Finn
NEW ENGLAND JOURNAL OF MEDICINE (2008)
VCAP-AMP-VECP compared with biweekly CHOP for adult T-Cell leukemia-lymphoma: Japan clinical oncology group study JCOG9801
Kunihiro Tsukasaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Defucosylated anti-CC chemokine receptor 4 monoclonal antibody combined with immunomodulatory cytokines: A novel immunotherapy for aggressive/refractory mycosis fungoides and Sezary syndrome
Hiroki Yano et al.
CLINICAL CANCER RESEARCH (2007)
Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL
Dolgor Baatar et al.
JOURNAL OF IMMUNOLOGY (2007)
Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies
Mitsuo Satoh et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
CCR4 as a novel molecular target for immunotherapy of cancer
Takashi Ishida et al.
CANCER SCIENCE (2006)
Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCC
Yutaka Kanda et al.
BIOTECHNOLOGY AND BIOENGINEERING (2006)
Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege
Takashi Ishida et al.
CANCER RESEARCH (2006)
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:: a randomised controlled trial by the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone:: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
W Hiddemann et al.
BLOOD (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma
R Niwa et al.
CANCER RESEARCH (2004)
CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified
T Ishida et al.
CLINICAL CANCER RESEARCH (2004)
The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-cell leukemia/lymphoma
T Ishida et al.
CLINICAL CANCER RESEARCH (2004)
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells
H Yagi et al.
INTERNATIONAL IMMUNOLOGY (2004)
Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma
K Tobinai et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109)
K Tsukasaki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity
T Shinkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Increased CCR4 expression in cutaneous T cell lymphoma
K Ferenczi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells
O Yoshie et al.
BLOOD (2002)
Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells
A Iellem et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational phase II-III trial results
M Duvic et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
